ORKA – oruka therapeutics, inc. (US:NASDAQ)

News

Oruka Therapeutics (NASDAQ:ORKA) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Oruka Therapeutics (NASDAQ:ORKA) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Oruka Therapeutics Announces New Board Member and Board Transition [Yahoo! Finance]
Oruka Therapeutics Announces New Board Member and Board Transition
Oruka Therapeutics (NASDAQ:ORKA) was downgraded by analysts at Wall Stre
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com